Insulin (Humalog/Humulin R) for Anabolic Nutrient Shuttling — Weight & Metabolism
EXTREMELY DANGEROUS when misused. FDA-approved for diabetes. Abused for anabolic nutrient partitioning. Hypoglycemia can cause death within minutes.
Overview
Insulin is an essential peptide hormone produced by pancreatic beta cells that is FDA-approved for the treatment of type 1 diabetes, type 2 diabetes, diabetic ketoacidosis, and hyperkalemia. In the context of performance enhancement, exogenous insulin is abused by an estimated 25% of advanced anabolic steroid users for its potent anabolic and nutrient-partitioning effects. Insulin is the most anabolic hormone in the human body — it drives glucose, amino acids, creatine, and other nutrients into skeletal muscle cells via GLUT4 transporter translocation and amino acid transporter upregulation. It simultaneously inhibits muscle protein breakdown (anti-catabolic) and stimulates protein synthesis through mTOR/S6K1 activation. Insulin also dramatically enhances glycogen synthesis, potentially increasing intramuscular glycogen storage by 50-100% above normal, contributing to increased muscle fullness and cellular hydration. However, insulin misuse for performance enhancement is EXTREMELY DANGEROUS. Hypoglycemia — the rapid, uncontrolled drop in blood glucose — can cause seizures, loss of consciousness, coma, brain damage, and death within minutes to hours. Unlike most performance-enhancing drugs, the margin between an "effective" dose and a lethal dose is razor-thin and varies dramatically based on individual insulin sensitivity, carbohydrate intake timing, exercise, and other factors. The most commonly abused formulations are rapid-acting insulin analogs (Humalog/lispro, onset 15 minutes, peak 1 hour, duration 3-4 hours) and regular human insulin (Humulin R, onset 30 minutes, peak 2-3 hours, duration 6-8 hours). Long-acting insulins (glargine, detemir) are almost never used for performance purposes due to unpredictable hypoglycemia over their 18-24+ hour duration. Multiple deaths have been documented in bodybuilders using exogenous insulin, and many more are suspected but attributed to other causes. Insulin is a prescription medication available without a prescription in some US states for emergency diabetes management.
Indications
- FDA-approved: Type 1 diabetes mellitus — essential replacement therapy
- FDA-approved: Type 2 diabetes mellitus — adjunctive therapy
- FDA-approved: Diabetic ketoacidosis (DKA) — emergency IV treatment
- FDA-approved: Hyperkalemia management — drives potassium intracellularly
- Abused: Anabolic nutrient partitioning in bodybuilding (~25% of advanced AAS users)
- Abused: Enhanced glycogen storage and muscle fullness
Mechanism of Action
Insulin injected subcutaneously in abdomen, thigh, or deltoid. Rapid-acting analogs (lispro) absorb within 15 minutes; regular insulin within 30 minutes. Absorption rate affected by injection site, depth, exercise, and temperature
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Insulin Lispro (Humalog) | 5-10 IU | Post-workout with 50-100g carbs | Rapid-acting: onset 15min, peak 1hr, duration 3-4hrs. MUST consume adequate carbs |
| Regular Insulin (Humulin R) | 5-10 IU | Post-workout with carbs+protein | Regular: onset 30min, peak 2-3hrs, duration 6-8hrs. Longer hypo window |
| Insulin Lispro (Humalog) | 10-15 IU | Post-workout | Advanced dose — significantly increased hypoglycemia risk. Emergency glucose mandatory |
| Regular Insulin | Per protocol | Continuous infusion | DKA/hyperkalemia ONLY — ICU/ER setting with continuous glucose monitoring |
Evidence Grade
GRADE D
Safety & Contraindications
- EXTREME HYPOGLYCEMIA RISK — can cause seizures, coma, and death within MINUTES
- NO margin for error — lethal dose varies unpredictably by individual sensitivity
- Multiple documented deaths in bodybuilders from insulin-induced hypoglycemia
- Must ALWAYS have fast-acting glucose source immediately available during use
- Never use alone — always have someone present who knows glucagon administration
- Fat gain with chronic use if caloric surplus exceeds muscle storage capacity
- Insulin sensitivity varies dramatically day-to-day based on diet, exercise, stress
- Drug interactions: beta-blockers mask hypoglycemia warning signs
- Long-acting insulins (glargine, detemir) — NEVER use for performance; uncontrollable hypo risk
- Insulin resistance can develop with chronic supraphysiological use
- Lipohypertrophy at injection sites with repeated use
- Available without prescription in some states — does not make it safe for non-medical use